Towa Barcelona Hub is the global digital and operational hub for Towa Pharmaceutical, a leading Japanese generic drug manufacturer. Based in Martorelles (Barcelona), Spain, this facility manages all international business activities outside of Japan, covering Europe, North America, and beyond.

Core Mission & Operations

• Global Hub: Established in 2020 following the acquisition of Pensa Pharma from the Spanish group Esteve, the Barcelona site now oversees operations in the US, Italy, and Portugal, distributing to over 40 countries.
• Research & Development: The site serves as a Center of Excellence, featuring a high-tech R&D center and a pilot plant dedicated to creating value-added generic medicines.
• Manufacturing Powerhouse: One of the largest plants in Europe, covering 35,000 m² with a production capacity exceeding 5.5 billion doses annually.

Key Details

• Workforce: Nearly 1,000 employees globally, with roughly 800 based in Spain.
• Innovation Investment: The company has invested over €100 million in the hub since 2019 to modernize facilities and expand its R&D pipeline.